A study to investigate safety, tolerability, pharmacokinetics and efficacy of REM0045392 compared with placebo in healthy participants
This research is investigating a new potential medicine, REM0045392, which is being developed for Alzheimer's disease. The main goals of this study are to make sure the medicine is safe when given to people for the first time, to see if people can tolerate it well (meaning they don't have too many bad side effects), and to understand how the body processes the medicine. This is a "Phase I" study, which means it's a very early step in testing a new treatment, typically done with healthy volunteers. The study will compare REM0045392 with a placebo (a dummy medicine) to help researchers learn as much as possible about its effects before it's tested in people who actually have Alzheimer's.
At a glance
What is this study about?
This study is about a new medicine called REM0045392, which scientists hope might one day help people with Alzheimer's disease. For now, researchers want to carefully test this new medicine in healthy people to learn more about it. Think of it like a brand new car model; before it's sold to the public, it goes through many tests to make sure it's safe to drive and that all its parts work correctly. This study is similar, but for a medicine.
The main things the researchers want to find out are if the medicine is safe to use and if people can take it without too many problems. They also want to understand what the medicine does inside the body – how long it stays, how it's broken down, and how quickly it leaves the body. This information is crucial for deciding if the medicine should be tested further in people living with Alzheimer's.
Because this is a very early study (it's called a Phase I trial), it's often done with healthy volunteers. This allows researchers to focus on the medicine's immediate effects and how the body handles it, without the added complexities of a disease. Some people will receive the new medicine, and others will receive a placebo – a substance that looks exactly like the medicine but has no active ingredients. This helps researchers accurately compare the effects of the actual medicine.
Key takeaways
- This study is testing a brand new medicine (REM0045392) for Alzheimer's disease.
- It's a very early-stage trial (Phase I), focusing on safety in healthy volunteers.
- Researchers want to understand how the medicine behaves in the body.
- You might receive the new medicine or a placebo (dummy medicine).
- Your participation could help develop future treatments for Alzheimer's.
- You can stop participating at any time.
Who may be eligible?
To join this study, you would need to be in good general health, as it's an early-stage trial designed to test the new medicine safely.
You can be male or female, and you need to be at least 18 years old. There's no upper age limit mentioned, but you would still need to meet other health requirements to take part.
The research staff will carefully check your medical history and do some health tests to ensure it's safe for you to participate and that you fit all the study's requirements.
- Are you generally healthy?
- Are you at least 18 years old?
- Are you comfortable potentially receiving a placebo?
- Are you able to attend several clinic visits, potentially including overnight stays?
This is a guide only — the research team will confirm whether you can take part.
What does participation involve?
If you decide to take part in this study, you would likely have several visits to the clinic. At these visits, doctors and nurses would perform various checks, like taking your blood pressure and temperature, and collecting blood or urine samples. You would also receive the study medication (either REM0045392 or the placebo).
The study usually involves staying at the clinic for a period after taking the medicine so that the medical team can closely monitor you for any effects or side effects. There might also be follow-up appointments after you leave the clinic to see how you are doing over time. The total duration of your participation, including all visits and follow-ups, would be explained to you in detail before you agree to join.
Potential risks and benefits
Locations (1)
- —Belgium
Common questions
What is a Phase I study?
A Phase I study is the very first time a new medicine is tested in humans. It's mainly to check if it's safe and how the body handles it, usually in healthy volunteers.
What is a placebo?
A placebo is a 'dummy' medicine that looks like the real thing but contains no active ingredients. It helps researchers compare the effects of the actual medicine.
Will I know if I'm getting the medicine or the placebo?
Usually, in these types of studies, neither you nor the study staff will know whether you are receiving the active medicine or the placebo. This is called 'blinding' and helps keep the results unbiased.
Will I get paid for taking part?
Sometimes, studies offer payments or cover travel expenses to compensate volunteers for their time and effort. This will be clearly explained to you before you join.
Can I leave the study if I change my mind?
Yes, absolutely. You can withdraw from the study at any time, for any reason, without needing to give an explanation and without it affecting your future medical care.
How to find out more
Always speak to your GP or specialist before deciding to take part in a study.
Discussion
Community discussion
Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.